The natural history of patients with squamous cell carcinoma of the hypopharynx

Laryngoscope

Volumn 118, Issue 8, 2008, Pages 1362-1371

  Hall, Stephen F ^a,c   Groome, Patti A ^a   Irish, Jonathan ^b   O'Sullivan, Brian ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c NONE   (Canada)

Author keywords

Hypopharynx; Natural history; Population based research; Squamous carcinoma

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CLINICAL FEATURE; COMORBIDITY; FEMALE; FUNCTIONAL STATUS; HUMAN; HYPOPHARYNX CANCER; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UNITED STATES; CANADA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DIABETES MELLITUS; DISEASE COURSE; GASTROINTESTINAL DISEASE; HYPOPHARYNX TUMOR; MIDDLE AGED; REGISTER; RESPIRATORY TRACT DISEASE; SOCIOECONOMICS; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; ONTARIO; REGISTRIES; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 49649113944     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e318173dc4a     Document Type: Article

References (27)

1. Robson A. Evidence-based management of hypopharyngeal cancer. Clin Otolaryngol 2002;27:413-420.
2. Abdelkarim SA. Cancer of the pyriform sinus: the trend towards conservative treatment. Bull Cancer 1997;84: 757-762.
3. Hoffman HT, Karnell LH, Shah J, Ayiyan S. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997;107: 1005-1017.
4. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A. Larynx preservation in pyriform sinus cancer: preliminary results of a EORTC phase III trial. J Natl Cancer Inst 1996;88:890-898.
5. Sewnaik A, Hoorweg J, Knegt P, et al. Treatment of hypopharyngeal cancer: analysis of nation-wide study in the Netherlands. Clin Otolaryngol 2005;30:52-57.
6. Eckel HE, Staar S, Volling P, Sittel C. Surgical treatment for hypopharyngeal carcinoma: feasibility, mortality and results. Otolaryngol Head Neck Surg 2001;124:561-569.
7. The Cancer Care and Epidemiology Division of Queen's Cancer Research Institute. Available at: http://qcri.queensu.ca/Cancer-Care-and-Epidemiology. html. Accessed April 25, 2008.
8. Groome P, Schulze K, Keller S, et al. Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol 2006;18:283-292.
9. Fritz A, Ries L. The SEER Program Code Manual. 3rd ed. Bethesda, MD: Cancer Statistics Branch, Division of Cancer Control and Population Sciences, US Department of Department of Health & Human Services; 1998.
10. TNM Classification of Malignant Tumours. 6th ed. New York: John Wiley & Sons; 2002.
11. Linn BS, Linn MW, Lee G. Cumulative Illness Rating Scale. J Am Ger Soc 1968;5:622-626.
12. Piccirillo JF, Tierney R, Costas I, et al. Prognostic importance of comorbidity in a hospital based cancer registry. JAMA 2004;291:2441-2447.
13. Miller MD, Towers A A Manual of Guidelines for Scoring of the Cumulative Illness Rating Scale for Geriatrics. Pittsburgh, PA University of Pittsburgh Department of Geriatric Psychiatry; 1991.
14. Miller MD, Paradis CF, Houck PR, Mazumbar S. Chronic medical illness burden in geropsychiatric patients: application of the Cumulative Illness Rating Scale. Psych Res 1992;41:237-248.
15. Hall S. A user's guide to measurements of comorbid illness. J Clin Epidemiol 2006;59:849-855.
16. Deleyiannis FW-B, Thomas DB, Vaughan TL, Davis S. Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst 1996;88:27-44.
17. Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974;27:387-404.
18. Greenfield S, Apalone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of post operative complications and one year recovery in patients undergoing total hip replacement. Medical Care 1993;31:141-154.
19. Groome PA, O'Sullivan B. Glottic cancer in Ontario Canada and the SEER areas of the United States: do different management philosophies produce different outcome profiles J Clin Epidemiol 2001;54:301-315.
20. Hall SF, Boysen M, Groome PA. Squamous cell carcinoma of the head and neck in Ontario, Canada and southeastern Norway. Laryngoscope 2003;113:695-701.
21. Mackillop W, Zhang-Salomons J, Groome PA, Paszat L. Socioeconomic status and cancer survival in Ontario. J Clin Oncol 2001;15:1680-1689.
22. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593-602.
23. Feinstein AR. On classifying cancers while treating patients. Arch Int Med 1985;145:1789-1791.
24. Hall S, Rochon P, Streiner D, et al. Measuring comorbidity for survival studies in head and neck oncology. Laryngoscope 2002;112:1988-1996.
25. Hall SF, Groome PA, Rothwell D. The impact of comorbidity on survival in patients with squamous cell carcinoma of the head and neck Head Neck 2000;22:317-322.
26. Andre K, Schraub S, Mercier M, Bontemps P. Role of alcohol and tobacco in the etiology of head and neck cancer. Eur J Cancer B Oral Oncol 1995;31b:301-309.
27. Barbera L, Groome PA, Mackillop W, et al. The role of computed tomography in the T classification of laryngeal carcinoma. Cancer 2001;91:394-407.